{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:28:22Z","timestamp":1767108502910},"reference-count":73,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A mixture of well-defined recombinant antigens together with an adjuvant that preferentially stimulates specific gamma interferon (IFN-\u03b3)-secreting helper type 1 CD4<jats:sup>+<\/jats:sup>T cells (Th1 cells) presents a rational option for a vaccine against leishmaniasis. The potential of this approach was investigated in murine infections with<jats:italic>Leishmania mexicana<\/jats:italic>, which are characterized by the absence of a parasite-specific Th1 response and uncontrolled parasite proliferation. A mixture of three antigens (glycoprotein 63, cysteine proteinases, and a membrane-bound acid phosphatase), which are all expressed in amastigotes, the mammalian stage of the parasite, were used for the immunization of C57BL\/6 mice in combination with six adjuvants (interleukin 12 [IL-12], Detox, 4\u2032-monophosphoryl lipid A, QS-21,<jats:italic>Mycobacterium bovis<\/jats:italic>BCG, and<jats:italic>Corynebacterium parvum<\/jats:italic>). All six vaccine formulations containing the mixture of recombinant antigens were protective against challenge infections with promastigotes, the insect stage of the parasite, in that mice controlled and healed infections but developed transient and, in certain cases, accentuated disease. The most effective adjuvants were IL-12 followed by Detox. Further studies using these two adjuvants showed that a similar protective effect was observed with a mixture of the corresponding native proteins, and mice which had controlled the infection showed a preponderance of IFN-\u03b3-secreting CD4<jats:sup>+<\/jats:sup>T cells in the lymph nodes draining the lesion. Using the recombinant proteins individually, it is shown that the relatively abundant cysteine proteinases and glycoprotein 63, but not the acid phosphatase, are able to elicit a protective response. The results are discussed in comparison to previous studies with subunit vaccines and with respect to cell biological aspects of antigen presentation in<jats:italic>Leishmania<\/jats:italic>-infected macrophages.<\/jats:p>","DOI":"10.1128\/iai.68.3.1328-1336.2000","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:01:19Z","timestamp":1027764079000},"page":"1328-1336","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":45,"title":["Subunit Vaccination of Mice against New World Cutaneous Leishmaniasis: Comparison of Three Proteins Expressed in Amastigotes and Six Adjuvants"],"prefix":"10.1128","volume":"68","author":[{"given":"Toni","family":"Aebischer","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Max-Planck-Institut fu\u0308r Biologie, Abteilung Membranbiochemie, D-72076 Tu\u0308bingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Wolfram","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Max-Planck-Institut fu\u0308r Biologie, Abteilung Membranbiochemie, D-72076 Tu\u0308bingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke I.","family":"Patzer","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Max-Planck-Institut fu\u0308r Biologie, Abteilung Membranbiochemie, D-72076 Tu\u0308bingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Ilg","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Max-Planck-Institut fu\u0308r Biologie, Abteilung Membranbiochemie, D-72076 Tu\u0308bingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wiese","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Max-Planck-Institut fu\u0308r Biologie, Abteilung Membranbiochemie, D-72076 Tu\u0308bingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Overath","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Max-Planck-Institut fu\u0308r Biologie, Abteilung Membranbiochemie, D-72076 Tu\u0308bingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-4758(94)90353-0"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/6.10.1535"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7904381"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.7.2952-2959.1993"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(82)90232-2"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.4049\/jimmunol.161.12.6794","article-title":"Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response","volume":"161","author":"Alexander J.","year":"1998","unstructured":"Alexander J. Coombs G. H. Mottram J. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.J. Immunol.161199867946801","journal-title":"J. Immunol."},{"key":"e_1_3_2_8_2","first-page":"409","article-title":"Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies","volume":"3","author":"Atkins M. B.","year":"1997","unstructured":"Atkins M. B. Robertson M. J. Gorodon M. Lotze M. T. DeCoste M. DuBois J. S. Ritz J. S. Sandler A. B. Edington A. B. Garzone P. D. Mier J. W. Canning C. M. Battiato L. Tahara H. Sherman M. L. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.Clin. Cancer Res.31997409417","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(93)90095-F"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90342-5"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.56.12.3272-3279.1988"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.24.11473"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0738-081X(96)00042-9"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.1.104"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)90116-4"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.617"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0074-02761995000400025"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/4000"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1137"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(97)01060-0"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.11.4261-4267.1995"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.5.1505"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1994.51.603"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.4049\/jimmunol.129.5.2206","article-title":"Prophylactic immunization against experimental leishmaniasis. I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection","volume":"129","author":"Howard J. G.","year":"1982","unstructured":"Howard J. G. Nicklin S. Hale C. Liew F. Y. Prophylactic immunization against experimental leishmaniasis. I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.J. Immunol.129198220022012","journal-title":"J. Immunol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(94)00126-X"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)81049-6"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.144.2.699","article-title":"Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis","volume":"144","author":"Jaffe C. L.","year":"1990","unstructured":"Jaffe C. L. Rachamim N. Sarfstein R. Characterization of two proteins from Leishmania donovani and their use for vaccination against visceral leishmaniasis.J. Immunol.1441990699706","journal-title":"J. Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.2.645"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00256-9"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4049\/jimmunol.135.3.2095","article-title":"Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection","volume":"135","author":"Liew F. Y.","year":"1985","unstructured":"Liew F. Y. Hale C. Howard J. G. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.J. Immunol.135198520952101","journal-title":"J. Immunol."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.8.3351-3359.1993"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(93)90241-O"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(89)90158-8"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(91)90152-V"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1987.44"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0031182000072243"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1995.11813017"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00220-5"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1369-5274(98)80065-9"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.12.6008"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7725103"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","unstructured":"Overath P. and Aebischer T. 1999. Antigen presentation by macrophages harboring intravesicular pathogens. Parasitol. Today 15: 325\u2013332.","DOI":"10.1016\/S0169-4758(99)01473-8"},{"key":"e_1_3_2_43_2","unstructured":"Patzer S. Leishmania mexicana: Expression in E. coli und Reinigung des Amastigoten-spezifischen GP63 und Isolierung der membrangebundenen sauren Phosphatase. Diploma thesis. 1994 Universit\u00e4t T\u00fcbingen T\u00fcbingen Germany."},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.4049\/jimmunol.150.6.2322","article-title":"Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis","volume":"150","author":"Rachamim N.","year":"1993","unstructured":"Rachamim N. Jaffe C. L. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis.J. Immunol.150199323222331","journal-title":"J. Immunol."},{"key":"e_1_3_2_45_2","first-page":"1","article-title":"Saponins as vaccine adjuvants","volume":"13","author":"Read Kensil C.","year":"1996","unstructured":"Read Kensil C. Saponins as vaccine adjuvants.Crit. Rev. Ther. Drug Carrier Syst.131996155","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.7.9.1475"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.13.040195.001055"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92659-P"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3024.1993.tb00587.x"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.57.3.875-881.1989"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.140.4.1274","article-title":"Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes","volume":"140","author":"Russell D. G.","year":"1988","unstructured":"Russell D. G. Alexander J. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.J. Immunol.140198812741279","journal-title":"J. Immunol."},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.6.4931-4939.1998"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4894-4899.1995"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-1651-8_2"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.4049\/jimmunol.160.8.3949","article-title":"Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis","volume":"160","author":"Sj\u00f6lander A.","year":"1998","unstructured":"Sj\u00f6lander A. Baldwin T. M. Curtis J. M. Handman E. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis.J. Immunol.160199839493957","journal-title":"J. Immunol."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.9.3559-3566.1995"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.4.1501"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(94)90143-0"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.6.1797"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.22.10267"},{"key":"e_1_3_2_61_2","unstructured":"Ulrich J. R. Cantrell J. L. Gustafson G. L. Myers K. R. Rudbach J. A. Hiernaux J. R. The adjuvant activity of monophosphoryl lipid A Topics in vaccine adjuvant research. Spriggs D. R. Koff W. C. 1990 137 143 CRC Press Boca Raton Fla"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-1823-5_21"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.176.1.47"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1998.9.13-1899"},{"key":"e_1_3_2_65_2","first-page":"637","article-title":"American cutaneous and mucocutaneous leishmaniasis","volume":"2","author":"Walton B. C.","year":"1987","unstructured":"Walton B. C. American cutaneous and mucocutaneous leishmaniasis The leishmaniases in biology and medicine Peters W. Killick-Kendrick R. 2. Clinical aspects and control 1987 637 664 Academic Press London, England","journal-title":"The leishmaniases in biology and medicine"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.9.2619"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-6851(96)02729-6"},{"key":"e_1_3_2_68_2","unstructured":"Wolfram M. Antigenpr\u00e4sentation durch Leishmania mexicana-infizierte Makrophagen. Ph.D. dissertation. 1996 Universit\u00e4t T\u00fcbingen T\u00fcbingen Germany."},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830261248"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250435"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90079-5"},{"key":"e_1_3_2_72_2","first-page":"173","article-title":"Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major","volume":"84","author":"Xu D.","year":"1995","unstructured":"Xu D. Liew F. Y. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major.Immunology841995173176","journal-title":"Immunology"},{"key":"e_1_3_2_73_2","first-page":"1","article-title":"Protection against Leishmania major infection in genetically susceptible BALB\/c mice by GP63 delivered orally in attenuated Salmonella typhimurium (AroA\u2212 AroD\u2212)","volume":"85","author":"Xu D.","year":"1995","unstructured":"Xu D. McSorley S. J. Chatfield S. N. Dougan G. Liew F. Y. Protection against Leishmania major infection in genetically susceptible BALB\/c mice by GP63 delivered orally in attenuated Salmonella typhimurium (AroA\u2212 AroD\u2212).Immunology85199517","journal-title":"Immunology"},{"key":"e_1_3_2_74_2","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.145.7.2281","article-title":"Oral Salmonella typhimurium (AroA\u2212) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis","volume":"145","author":"Yang D. M.","year":"1990","unstructured":"Yang D. M. Fairweather N. Button L. L. McMaster W. R. Kahl L. P. Liew F. Y. Oral Salmonella typhimurium (AroA\u2212) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis.J. Immunol.145199022812285","journal-title":"J. Immunol."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.3.1328-1336.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.3.1328-1336.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:15:47Z","timestamp":1682262947000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.68.3.1328-1336.2000"}},"subtitle":[],"editor":[{"given":"J. M.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1128\/IAI.68.3.1328-1336.2000"],"URL":"https:\/\/doi.org\/10.1128\/iai.68.3.1328-1336.2000","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]},"assertion":[{"value":"1999-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-11-29","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}